Posted on

Why your employer should let you do drugs

PSYCH: THE PSYCHEDELICS AS MEDICINE REPORT

Psych’s third annual report on psychedelic medicine revealed some interesting findings.

According to a survey of 440 healthcare professionals working in various fields, two thirds said they were excited about psychedelics as medicines. Of those who’ve personally tried the drugs for therapeutic or spiritual purposes, 83% were in favour of psychedelic medicine.

Consumers also showed a positive view of psychedelics, with about two thirds supporting medical legalization and 38% noting that someone they know would benefit from psychedelic therapy. When asked which psychedelic they would want to try in therapy, psilocybin and salvia were the most popular choices.

The report also showed that psychedelic therapy could save employers US$64 billion in Europe and US$270 billion in America due to fewer sick days and increased productivity.

PDF of report

Posted on

Childhood trauma? Try tripping 5 times

Psychedelics might reduce internalized shame and complex trauma symptoms in those with a history of childhood abuse

A recent study suggests that repeated psychedelic drug use may be effective in reducing PTSD symptoms and internalized shame in people who endured maltreatment during childhood.

The researchers surveyed adults with severe physical, emotional, or sexual trauma and found that those who took psychedelics for therapeutic purposes (in non-clinical settings) were less likely to have a negative self-concept or disturbances in relationships.

Participants who used psychedelics with therapeutic intent 5 times showed the lowest levels of internalized shame and complex trauma.

PDF of article

PDF of study

Posted on

Even boomers want to microdose

Red Light Oregon Market Research Shows High Interest in Psilocybin Services With 86% of Adults Interested in Microdosing

New market research shows a growing interest in psilocybin services!

Red Light Oregon, a 50/50 joint venture between Red Light Holland (TRUFF) and Halo Collective (HALO), conducted market research to help the Oregon Psilocybin Advisory Board (OPAB) and health officials make informed regulations.

Of 473 Oregonian adults surveyed, 86% showed in interest in microdosing, including 94% of Gen Z and 74% of Boomers. 84% said they were interested in the mental health effects of psilocybin, with 49% interested in paying for psilocybin services. As a result, Red Light Oregon launched an advocacy program to educate the OPAB and health officials on the benefits of microdosing.

The survey also found that 37% of adults, mainly minorities, did not know what psilocybin is, so the company is launching a community outreach program to educate underserved populations on psilocybin’s therapeutic effects.

PDF of article

Posted on

Tapping into traditional healing

Goodness Growth Holdings™ Subsidiary Resurgent Biosciences Launches First IRB-Approved Research Study on Entheogens & Psychedelic Experiences

Resurgent Biosciences, a subsidiary of Goodness Growth Holdings (GDNS), is tapping into the spiritual and cultural side of psychedelics to develop a better approach to psychedelic therapy.

The company is launching a study on the naturalistic use of entheogens through a partnership with Flor da Jurema, a temple community in Brazil where visitors can take part in spiritual experiences with traditional plant medicines.

The study, which was just approved by an independent Institutional Review Board, will survey 100 adults who have participated in entheogen therapy centers or psychedelic retreats in the last five years.

The goal is to get a sense of their intentions, motivations, experiences, demographics, and willingness to participate in entheogen research in the future and use the findings to create more positive, long-lasting results from psychedelic-assisted therapies.

PDF of article

Posted on

Escaping boredom with altered consciousness

College students reported record-high marijuana use and record-low drinking in 2020, study says

To escape the boredom and stress of the pandemic, college students are turning to psychedelics and marijuana.

A recent study found that psychedelic drug use among college students nearly doubled during the pandemic, increasing from 5% in 2019 to 9% in 2020. For non-college young adults, use increased from 8% to 10%.

College students also reported record-high marijuana use and record-low levels of alcohol consumption and binge drinking, likely as a result of fewer social events.

Experts predict that these trends reflect need to cope with mental health issues the desire to break monotony with a different mental state.

Posted on

Losing weight with shrooms?

Psychedelic drug users tend to have better overall physical health than non-users, study finds

Psychedelic drug users might be healthier than non-users, according to a recent study.

A survey of over 170,000 people showed that those who have used psychedelic drugs (14% of respondents) reported better overall health and were significantly less likely to be overweight or obese compared to non-users. The University of Oxford researchers suggest that transcendent psychedelic experiences might result in “long-term changes in health behavior that contribute to better physical health.”

PDF of article

PDF of study

Posted on

Taking shrooms is good for society

The relationships of classic psychedelic use with criminal behavior in the United States adult population

Research suggests that psychedelic drug use is linked to decreased criminal behaviour.

An analysis of 13 years worth of survey data revealed that psychedelic drug use was associated with decreased odds of past year theft, assault, arrest for property crime, and arrest for violent crimes by 27%, 12%, 22%, and 18%, respectively.

The use of other illegal drugs was associated with increased odds of criminal behaviour.

“These findings are consistent with a growing body of research suggesting classic psychedelics confer enduring psychological and prosocial benefits.”